- |||||||||| Avastin (bevacizumab) / Roche, lifastuzumab vedotin (DNIB0600A) / Roche
Enrollment closed, Enrollment change, Trial primary completion date, Combination therapy: A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer (clinicaltrials.gov) - Sep 15, 2016 P1, N=33, Active, not recruiting, Active, not recruiting --> Completed | Trial primary completion date: Jan 2016 --> Aug 2016 Recruiting --> Active, not recruiting | N=42 --> 33 | Trial primary completion date: Sep 2015 --> Dec 2016
|